| Treatment |
Disease severity |
| 2014 |
2015 |
| 1st spray |
2nd spray |
3rd spray |
Mean |
1st Spray |
2nd Spray |
3rd Spray |
Mean |
| T1 |
19.6 |
13.3 |
9.0 |
13.9 |
17.5 |
12.3 |
7.0 |
12.2 |
| T2 |
21.0 |
18.0 |
11.6 |
22.3 |
20.0 |
17.0 |
9.6 |
15.5 |
| T3 |
32.0 |
19.0 |
16.0 |
22.3 |
19.0 |
18.0 |
14.0 |
17.0 |
| T4 |
35.3 |
20.3 |
17.0 |
24.1 |
30.3 |
20.3 |
15.0 |
21.8 |
| T5 |
38.3 |
23.6 |
20.0 |
27.3 |
38.3 |
22.6 |
19.0 |
26.6 |
| T6 |
28.3 |
32.6 |
16.3 |
25.7 |
26.3 |
30.6 |
15.3 |
24.6 |
| T7 |
23.8 |
23.0 |
15.3 |
20.0 |
22.6 |
20.0 |
14.3 |
18.9 |
| T8 |
29.0 |
27.0 |
20.3 |
25.4 |
28.0 |
26.6 |
19.3 |
24.0 |
| T9 |
23.3 |
22.0 |
17.3 |
20.8 |
22.6 |
21.0 |
16.3 |
19.9 |
| T10 |
35.3 |
23.6 |
20.6 |
26.4 |
18.3 |
15.6 |
12.6 |
15.4 |
| T11 |
40.3 |
29.0 |
20.6 |
29.9 |
39.6 |
28.0 |
18.3 |
28.6 |
| T12 |
41.6 |
27.0 |
19.3 |
29.3 |
40.0 |
26.6 |
20.5 |
29.0 |
| Switch (T13) |
13.6 |
8.6 |
5.3 |
9.16 |
13.6 |
7.6 |
4.3 |
8.5 |
| Untreated control (T14) |
55.7 |
53.3 |
54.0 |
54.3 |
56.o |
53.3 |
50.0 |
53.1 |
| L.S.D at 5% |
0.58 |
0.92 |
1.29 |
|
0.60 |
0.95 |
1.30 |
|
|
